193 related articles for article (PubMed ID: 32047502)
21. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
22. Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice.
Fousteri G; Jofra T; Di Fonte R; Gagliani N; Morsiani C; Stabilini A; Battaglia M
Diabetologia; 2015 Jun; 58(6):1319-28. PubMed ID: 25748328
[TBL] [Abstract][Full Text] [Related]
23. Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice.
Sood S; Brownlie RJ; Garcia C; Cowan G; Salmond RJ; Sakaguchi S; Zamoyska R
J Immunol; 2016 Jul; 197(2):429-40. PubMed ID: 27288531
[TBL] [Abstract][Full Text] [Related]
24. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant.
Zheng P; Kissler S
Diabetes; 2013 Mar; 62(3):896-904. PubMed ID: 23193190
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the
Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
[TBL] [Abstract][Full Text] [Related]
26. CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice.
Shin JY; Yoon IH; Lim JH; Shin JS; Nam HY; Kim YH; Cho HS; Hong SH; Kim JS; Lee WW; Park CG
Cell Mol Immunol; 2015 Sep; 12(5):592-603. PubMed ID: 26211666
[TBL] [Abstract][Full Text] [Related]
27. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
28. CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia.
Vanasek TL; Nandiwada SL; Jenkins MK; Mueller DL
J Immunol; 2006 May; 176(10):5880-9. PubMed ID: 16670295
[TBL] [Abstract][Full Text] [Related]
29. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity.
Housley WJ; Adams CO; Vang AG; Brocke S; Nichols FC; LaCombe M; Rajan TV; Clark RB
J Immunol; 2011 Oct; 187(8):4161-9. PubMed ID: 21908737
[TBL] [Abstract][Full Text] [Related]
31. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
32. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
33. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
Setoguchi R; Hori S; Takahashi T; Sakaguchi S
J Exp Med; 2005 Mar; 201(5):723-35. PubMed ID: 15753206
[TBL] [Abstract][Full Text] [Related]
34. B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis.
Yu S; Maiti PK; Dyson M; Jain R; Braley-Mullen H
J Exp Med; 2006 Feb; 203(2):349-58. PubMed ID: 16446379
[TBL] [Abstract][Full Text] [Related]
35. A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease.
Killebrew JR; Perdue N; Kwan A; Thornton AM; Shevach EM; Campbell DJ
J Immunol; 2011 Jul; 187(2):861-9. PubMed ID: 21690323
[TBL] [Abstract][Full Text] [Related]
36. Protein tyrosine phosphatase PTPN22 is dispensable for dendritic cell antigen processing and promotion of T-cell activation by dendritic cells.
Clarke F; Jordan CK; Gutiérrez-Martinez E; Bibby JA; Sanchez-Blanco C; Cornish GH; Dai X; Rawlings DJ; Zamoyska R; Guermonprez P; Cope AP; Purvis HA
PLoS One; 2017; 12(10):e0186625. PubMed ID: 29040339
[TBL] [Abstract][Full Text] [Related]
37. Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice.
Lu Y; Suzuki J; Guillioli M; Umland O; Chen Z
Immunology; 2011 Sep; 134(1):50-9. PubMed ID: 21711461
[TBL] [Abstract][Full Text] [Related]
38. Homeostatic proliferation in the mice with germline FoxP3 mutation and its contribution to fatal autoimmunity.
Chang X; Zheng P; Liu Y
J Immunol; 2008 Aug; 181(4):2399-406. PubMed ID: 18684929
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase PTPN22 has dual roles in promoting pathogen versus homeostatic-driven CD8 T-cell responses.
Jofra T; Di Fonte R; Hutchinson TE; Dastmalchi F; Galvani G; Battaglia M; Salek-Ardakani S; Fousteri G
Immunol Cell Biol; 2017 Feb; 95(2):121-128. PubMed ID: 27725666
[TBL] [Abstract][Full Text] [Related]
40. Type 1 diabetes linked PTPN22 gene polymorphism is associated with the frequency of circulating regulatory T cells.
Valta M; Gazali AM; Viisanen T; Ihantola EL; Ekman I; Toppari J; Knip M; Veijola R; Ilonen J; Lempainen J; Kinnunen T
Eur J Immunol; 2020 Apr; 50(4):581-588. PubMed ID: 31808541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
